Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients (Q22338048)

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Apraclonidine. A one-week dose-response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Apraclonidine Primary Therapy Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Apraclonidine and timolol. Combined effects in previously untreated normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Effect of apraclonidine on blood-aqueous barrier permeability to plasma protein in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Brimonidine tartrate: a one-month dose response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Selective alpha 2-adrenergic agonists B-HT 920 and UK14304-18. Effects on aqueous humor dynamics in monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Comparison of the efficacy of apraclonidine and brimonidine as aqueous suppressants in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Effects of apraclonidine on aqueous humor dynamics in human eyes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Effects of brimonidine on aqueous humor dynamics in human eyes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Fluorophotometric study of epinephrine and timolol in human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Vitreous fluorophotometry for clinical research. I. Description and evaluation of a new fluorophotometer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Trabecular outflow facility determined by fluorophotometry in human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Ocular effects of a relatively selective alpha 2 agonist (UK-14, 304-18) in cats, rabbits and monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Circadian intraocular pressure management with latanoprost: diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Effects of topical PGF2 alpha on aqueous humor dynamics in cynomolgus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Prostaglandin F2 alpha increases uveoscleral outflow in the cynomolgus monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

The effect of topical PGF2 alpha on uveoscleral outflow and outflow facility in the rabbit eye.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8

Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900076-8